NCIt definition : A second-generation, orally bioavailable dual kinase inhibitor with potential antineoplastic
activity. EGFR/HER2 inhibitor AV-412 binds to and inhibits the epidermal growth factor
receptor (EGFR) and the human epidermal growth factor receptor 2 (HER2), which may
result in the inhibition of tumor growth and angiogenesis, and tumor regression in
EGFR/HER2-expressing tumors. This agent may be active against EGFR/HER2-expressing
tumor cells that are resistant to first-generation kinase inhibitors. EGFR and HER2
are receptor tyrosine kinases that play major roles in tumor cell proliferation and
tumor vascularization.;